| Literature DB >> 16564110 |
Abstract
One of the mantras of scientists working in the field of pharmacogenetics is 'the right dose for the right patient'. A recent article has gone someway towards demonstrating that this goal can be achieved using genetic approaches. It is one of the first reports to show that a specific polymorphism can predict the maximum tolerated dose of two anti-epileptic drugs. However, further studies are necessary to validate these observations.Entities:
Mesh：
Year: 2006 PMID： 16564110 DOI： 10.1016/j.tig.2006.03.004
Source DB: PubMed Journal: Trends Genet ISSN： 0168-9525 Impact factor: 11.639